Lucira Health is a medical technology company focused on the development and commercialization of infectious disease test kits. Co. has developed a testing platform that produces molecular testing in a single-use test kit that is powered by two AA batteries and fits in the palm of a hand. Co.'s primary commercially available polymerase chain reaction-quality diagnostic test is the LUCIRA COVID-19 All-In-One Test Kit. The LHDX average annual return since 2021 is shown above.
The Average Annual Return on the LHDX average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether LHDX average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the LHDX average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|